Navigation Links
Accera, Inc. Sponsors Alzheimer's Association's 2009 ICAD Conference
Date:2/17/2009

BROOMFIELD, Colo., Feb. 17 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) diseases, announced today it is a SILVER level sponsor of the 2009 International Conference on Alzheimer's Disease (ICAD). The annual conference, put on by the Alzheimer's Association, is the world's leading forum on dementia research. ICAD 2009 will take place July 11-16 in Vienna, Austria.

"Alzheimer's is a progressive and fatal disease that significantly impacts millions of patients, their families and caregivers," said Steve Orndorff, Ph.D., Accera's founder and CEO. "As a company focused on CNS disorders, Accera is committed to improving the care and quality of life of Alzheimer's patients who are in need of innovative, safe, new therapeutic options. By supporting ICAD we are joining the Alzheimer's Association in their quest to advance research, care and support for AD."

In the U.S., 5.2 million people are living with AD and it has become the sixth leading cause of death. There is currently no cure for AD and there is a tremendous need for new and innovative therapies.

ICAD 2009 is expected to draw approximately 5,000 researchers, clinicians and neurologists from around the world to engage in a multidisciplinary exchange of ideas. The international sharing of research looks to advance prevention methods, treatments and a cure for AD.

About ICAD

The Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) is the largest gathering of international leaders in Alzheimer research and care. At ICAD, researchers from around the world share groundbreaking information and resources on the cause, diagnosis, treatment and prevention of Alzheimer's and related disorders. As a part of the Association's research program, ICAD serves as a catalyst for generating new knowledge about dementia and fostering a vital, colle
'/>"/>

SOURCE Accera, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Accera, Inc. to Present at the 4th Annual BIO Investor Forum
2. Accera, Inc. Names William T. Poncy Vice President of Commercial Development
3. Accera, Inc. Completes $35 Million Series C Financing
4. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
5. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
6. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
7. Baxa Announces Colorado BioScience Association Sponsorship
8. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
9. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
10. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
11. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... - Results From a Survey Conducted ... Seven Major Industrialized Countries , , - ... disease, impacts their enjoyment of ... rheumatoid arthritis find shopping for gifts, ... difficult to do, ...
(Date:12/11/2009)... miRagen Therapeutics, Inc., a biopharmaceutical company focused ... therapeutics for cardiovascular and muscle disease, today announced ... plays a crucial role in the progression of ... and in neuromuscular synaptic regeneration in mice. ... of the journal Science , reveal miR-206 ...
(Date:12/11/2009)... Ambit Biosciences Corporation announced today the enrollment ... Anderson Cancer Center of the first patient in the ... E fficacy) Phase 2 pivotal trial in patients ... AC220 is a novel, orally available, potent and highly ... FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ACE study ...
(Date:12/11/2009)... Gwathmey, Inc., a pre-clinical contract research organization and ... cardiovascular disease announces a new CEO. ... Ph.D., has joined Gwathmey as Chief Executive Officer. ... experience working with small businesses and the federal ... managed multimillion dollar portfolios for the National Institutes ...
Breaking Biology Technology:Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
... CAMBRIDGE, Mass., July 2 Biopure Corporation,(Nasdaq: BPUR ... with,purchasers for a private placement of its common stock ... no exercise of the warrants. The,company intends to use ... The first closing occurred on June 30, 2008, and,subsequent ...
... Vice President, Marketing and Sales; Susan Koppy ... as Vice President, Corporate Development, PT. RICHMOND, Calif., July ... Moore to the position of,Vice President, Marketing and Sales and ... Mr. Moore and Ms. Koppy will report,to President & Chief ...
... 2 Pearl Therapeutics, Inc.,a biopharmaceutical company developing ... has completed the closing of an $18,million round ... extension to,its first venture financing, which closed in ... existing investors Clarus Ventures, New Leaf,Ventures, 5AM Ventures ...
Other Biology Technology:Biopure Announces Private Equity Financing 2Biopure Announces Private Equity Financing 3Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors 2
(Date:12/14/2009)... date of the proteins in a species of salamander ... how similar regeneration could be induced in humans. ... University-Purdue University Indianapolis and colleagues investigated over three hundred ... of salamander that has the unique natural ability to ... hope that this knowledge will contribute to a better ...
(Date:12/14/2009)... once thought of tool use as a defining feature of ... other primates, along with birds and an array of other ... Current Biology , a Cell Press publication, adds an ... veined octopus under study manages a behavioral trick that the ... itself over stacked, upright coconut shell "bowls," makes its eight ...
(Date:12/14/2009)... As good as laparoscopy is in preventing some of the ... drawbacks, including reduced blood flow and organ dysfunction. Laparoscopy is ... incisions. , By adding another gas ... during laparoscopy, researchers at Duke University Medical Center have found ... , The gas ethyl nitrite (ENO) helped to open ...
Breaking Biology News(10 mins):IUPUI researchers tackle protein mechanisms behind limb regeneration 2Tool use in an invertebrate: The coconut-carrying octopus 2Gas improves blood flow and organ status during minimally invasive surgery 2Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 1Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 2Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 3Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 4Cardinal Health Completes Biotech Acquisition 13325 1Cardinal Health Completes Biotech Acquisition 13325 2Vitamin D Deficiency Linked to Heart Risk Factors in Kids 53470 1Vitamin D Deficiency Linked to Heart Risk Factors in Kids 53470 2Vitamin D Deficiency Linked to Heart Risk Factors in Kids 53470 3
... release is available in French . ... the chilli cook-off, usually has a key secret ingredient, ... crucial proteins, which change the dynamics of cells from ... involving McGill University, the Research Institute of the McGill ...
... described the sudden origin of flowering plants about 130 million ... yet to solve. , But a new University of ... edition of the Proceedings of the National Academy of ... information about what the first flowers looked like and how ...
... hydrogen on an environmentally friendly and cost-effective basis by ... E.ON research award. , The new process of producing ... sunlight, biomass and water. It combines solar driven cleavage ... the use of energy derived from fossil fuels and ...
Other Biology News:Proteomics: Finding the key ingredients of disease 2University of Florida study provides insight into evolution of first flowers 2University of Florida study provides insight into evolution of first flowers 3Accolade for solar-hydrogen project 2
... quality running into billions of dollars ... increasing pressure to reduce expensive rework ... distribution of ingredients is known to ... dissolution, stability, bio-availability and hardness. However, ...
This free-standing laminar flow hood provides a vertical flow of HEPA-filtered air to create a clean processing area. It includes a fluorescent light and motorized sliding shield. Options include wor...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: rack ...
... , ,Product Information , ,The three ... is extremely efficient, yet gentle, making this ... as staining gels, hybridization and other applications. ... broad range. A nonslip rubber mat and ...
Biology Products: